Baltimore-washington Financial Advisors buys $7,004,673 stake in Stryker Corporation (SYK)

Stryker Corporation (SYK) : Baltimore-washington Financial Advisors scooped up 8,730 additional shares in Stryker Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 2, 2016. The investment management firm now holds a total of 62,986 shares of Stryker Corporation which is valued at $7,004,673.Stryker Corporation makes up approximately 2.13% of Baltimore-washington Financial Advisors’s portfolio.

Stryker Corporation opened for trading at $109.82 and hit $111.21 on the upside on Friday, eventually ending the session at $111.21, with a gain of 0.99% or 1.09 points. The heightened volatility saw the trading volume jump to 17,49,300 shares. Company has a market cap of $41,590 M.

Other Hedge Funds, Including , Wedbush Securities Inc boosted its stake in SYK in the latest quarter, The investment management firm added 500 additional shares and now holds a total of 5,751 shares of Stryker Corporation which is valued at $639,569. Stryker Corporation makes up approx 0.11% of Wedbush Securities Inc’s portfolio.Van Hulzen Asset Management boosted its stake in SYK in the latest quarter, The investment management firm added 1,817 additional shares and now holds a total of 36,811 shares of Stryker Corporation which is valued at $4,012,767. Stryker Corporation makes up approx 2.29% of Van Hulzen Asset Management’s portfolio.Tiaa Cref Trust Co Fsbmo reduced its stake in SYK by selling 40,302 shares or 36.51% in the most recent quarter. The Hedge Fund company now holds 70,094 shares of SYK which is valued at $7,668,284. Stryker Corporation makes up approx 0.07% of Tiaa Cref Trust Co Fsbmo’s portfolio.

On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.

Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Upgraded by Sterne Agee CRT to ” Buy” on Apr 27, 2016. Company shares were Reiterated by RBC Capital Mkts on Apr 26, 2016 to “Outperform”, Firm has raised the Price Target to $ 120 from a previous price target of $108 .Company shares were Downgraded by Robert W. Baird on Apr 13, 2016 to ” Neutral”, Firm has raised the Price Target to $ 116 from a previous price target of $111 .

Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.

Leave a Reply

Stryker Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Stryker Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.